SCHEMBL7879971

SCHEMBL7879971

CC1(C)CCC(C)(C)c2c(C(=O)Cl)cccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
RXRA P19793 14/20 0.38
RARB P10826 10/20 0.38
RARG P13631 8/20 0.38
RARA P10276 5/20 0.38
ALDH1A1 P00352 1/20 0.37
ALOX15 P16050 1/20 0.37
RXRB P28702 3/20 0.36
RXRG P48443 3/20 0.36
HNF4A P41235 2/20 0.35
MEN1 O00255 1/20 0.35
CYP26A1 O43174 1/20 0.35
ABCB11 O95342 1/20 0.35
ESR1 P03372 1/20 0.35
PGR P06401 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8919744 0.79 RXRA (0.44) RXRARARBRARGRARARXRB
SCHEMBL7778758 0.76 TP53 (0.43) TP53CYP1A2RXRARARBRARG
SCHEMBL16861460 0.74 ALDH1A1 (0.44) TP53CYP1A2ALDH1A1ALOX15
SCHEMBL29119948 0.71 ALDH1A1 (0.41) TP53RARBRARGALDH1A1ALOX15
SCHEMBL23446684 0.71 CYP1A2 (0.44) TP53CYP1A2RXRARARBRARG
SCHEMBL6430449 0.70 RXRA (0.43) TP53CYP1A2RXRARARBRARG
SCHEMBL29119960 0.70 ALDH1A1 (0.40) RARBRARGRARAALDH1A1ALOX15
SCHEMBL7943899 0.70 RARB (0.67) TP53CYP1A2RXRARARBRARG
SCHEMBL7943904 0.70 RARB (0.67) TP53CYP1A2RXRARARBRARG
SCHEMBL7872153 0.69 RXRA (0.59) RXRARARBRARGRARARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6326510-B1 SKIN DISORDERS; ANTICANCER AGENTS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-12-04 US disclosed